baclofen has been researched along with Diabetes Mellitus, Type 1 in 5 studies
Diabetes Mellitus, Type 1: A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 49-year-old male with type 1 diabetes presented with a 6-month history of muscle rigidity and spasms of his upper and lower extremities." | 2.46 | Stiff-person syndrome: a case report and review of the literature. ( Chedebeau, F; Egwuonwu, S, 2010) |
| "This, in turn, leads to several eye movement disorders, including spontaneous downbeat (DBN) and periodic alternating nystagmus." | 1.48 | Disabling Central Paroxysmal Positioning Upbeat Nystagmus and Vertigo Associated With the Presence of Anti-Glutamic Acid Decarboxylase Antibodies. ( Amorim, AM; Carvalho, JN; Eggenberger, E; Geraldo, A; Lemos, J; Martins, AI, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Martins, AI | 1 |
| Carvalho, JN | 1 |
| Amorim, AM | 1 |
| Geraldo, A | 1 |
| Eggenberger, E | 1 |
| Lemos, J | 1 |
| Egwuonwu, S | 1 |
| Chedebeau, F | 1 |
| Beales, PE | 1 |
| Hawa, M | 1 |
| Williams, AJ | 1 |
| Albertini, MC | 1 |
| Giorgini, A | 1 |
| Pozzilli, P | 1 |
| Seitz, RJ | 1 |
| Blank, B | 1 |
| Kiwit, JC | 1 |
| Benecke, R | 1 |
| Coiro, V | 1 |
| Capretti, L | 1 |
| Bianconi, L | 1 |
| Castelli, A | 1 |
| Cerri, L | 1 |
| Roberti, G | 1 |
| Marcato, A | 1 |
| Volpi, R | 1 |
| Chiodera, P | 1 |
2 reviews available for baclofen and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Stiff-person syndrome: a case report and review of the literature.
Topics: Anemia, Pernicious; Anti-Anxiety Agents; Baclofen; Diabetes Mellitus, Type 1; Diagnosis, Differentia | 2010 |
Stiff-person syndrome with anti-glutamic acid decarboxylase autoantibodies: complete remission of symptoms after intrathecal baclofen administration.
Topics: Autoantibodies; Baclofen; Diabetes Mellitus, Type 1; Female; Glutamate Decarboxylase; Humans; Inject | 1995 |
1 trial available for baclofen and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Reduction of baclofen-, but not sodium valproate-induced growth hormone release in type I diabetic men.
Topics: Adult; Baclofen; Diabetes Mellitus, Type 1; gamma-Aminobutyric Acid; Growth Hormone; Humans; Male; R | 1991 |
2 other studies available for baclofen and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Disabling Central Paroxysmal Positioning Upbeat Nystagmus and Vertigo Associated With the Presence of Anti-Glutamic Acid Decarboxylase Antibodies.
Topics: Aged; Autoantibodies; Baclofen; Diabetes Mellitus, Type 1; Female; GABA-B Receptor Agonists; Glutama | 2018 |
Baclofen, a gamma-aminobutyric acid-b receptor agonist, delays diabetes onset in the non-obese diabetic mouse.
Topics: Aging; Animals; Baclofen; Diabetes Mellitus, Type 1; Female; GABA-B Receptor Antagonists; Glutamate | 1995 |